Literature DB >> 22753932

Chronic activation of the kinase IKKβ impairs T cell function and survival.

Sruti Krishna1, Danli Xie, Balachandra Gorentla, Jinwook Shin, Jimin Gao, Xiao-Ping Zhong.   

Abstract

Activation of the transcription factor NF-κB is critical for cytokine production and T cell survival after TCR engagement. The effects of persistent NF-κB activity on T cell function and survival are poorly understood. In this study, using a murine model that expresses a constitutively active form of inhibitor of NF-κB kinase β (caIKKβ) in a T cell-specific manner, we demonstrate that chronic inhibitor of NF-κB kinase β signaling promotes T cell apoptosis, attenuates responsiveness to TCR-mediated stimulation in vitro, and impairs T cell responses to bacterial infection in vivo. caIKKβ T cells showed increased Fas ligand expression and caspase-8 activation, and blocking Fas/Fas ligand interactions enhanced cell survival. T cell unresponsiveness was associated with defects in TCR proximal signaling and elevated levels of B lymphocyte-induced maturation protein 1, a transcriptional repressor that promotes T cell exhaustion. caIKKβ T cells also showed a defect in IL-2 production, and addition of exogenous IL-2 enhanced their survival and proliferation. Conditional deletion of B lymphocyte-induced maturation protein 1 partially rescued the sensitivity of caIKKβ T cells to TCR triggering. Furthermore, adoptively transferred caIKKβ T cells showed diminished expansion and increased contraction in response to infection with Listeria monocytogenes expressing a cognate Ag. Despite their functional defects, caIKKβ T cells readily produced proinflammatory cytokines, and mice developed autoimmunity. In contrast to NF-κB's critical role in T cell activation and survival, our study demonstrates that persistent IKK-NF-κB signaling is sufficient to impair both T cell function and survival.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753932      PMCID: PMC3401317          DOI: 10.4049/jimmunol.1102429

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 2.  Death receptor signal transducers: nodes of coordination in immune signaling networks.

Authors:  Nicholas S Wilson; Vishva Dixit; Avi Ashkenazi
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

3.  PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes.

Authors:  Z Sun; C W Arendt; W Ellmeier; E M Schaeffer; M J Sunshine; L Gandhi; J Annes; D Petrzilka; A Kupfer; P L Schwartzberg; D R Littman
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

4.  Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.

Authors:  J Ruland; G S Duncan; A Elia; I del Barco Barrantes; L Nguyen; S Plyte; D G Millar; D Bouchard; A Wakeham; P S Ohashi; T W Mak
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

Review 5.  NF-κB family of transcription factors: biochemical players of CD28 co-stimulation.

Authors:  Loretta Tuosto
Journal:  Immunol Lett       Date:  2010-09-21       Impact factor: 3.685

6.  Lymphocytes lacking I kappa B-alpha develop normally, but have selective defects in proliferation and function.

Authors:  C L Chen; N Singh; F E Yull; D Strayhorn; L Van Kaer; L D Kerr
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

7.  Tight regulation of diacylglycerol-mediated signaling is critical for proper invariant NKT cell development.

Authors:  Shudan Shen; Jinhong Wu; Sruti Srivatsan; Balachandra K Gorentla; Jinwook Shin; Li Xu; Xiao-Ping Zhong
Journal:  J Immunol       Date:  2011-07-20       Impact factor: 5.422

8.  Biochemical and genetic evidence for a SAP-PKC-theta interaction contributing to IL-4 regulation.

Authors:  Jennifer L Cannons; Julie Z Wu; Julio Gomez-Rodriguez; Jinyi Zhang; Baoxia Dong; Yin Liu; Stephen Shaw; Katherine A Siminovitch; Pamela L Schwartzberg
Journal:  J Immunol       Date:  2010-07-28       Impact factor: 5.422

9.  Blimp-1/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation.

Authors:  Marc A J Morgan; Erna Magnusdottir; Tracy C Kuo; Chai Tunyaplin; James Harper; Sebastian J Arnold; Kathryn Calame; Elizabeth J Robertson; Elizabeth K Bikoff
Journal:  Mol Cell Biol       Date:  2009-09-08       Impact factor: 4.272

10.  RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1.

Authors:  Xiaobo Wang; Karine Belguise; Christine F O'Neill; Nuria Sánchez-Morgan; Mathilde Romagnoli; Sean F Eddy; Nora D Mineva; Ziyang Yu; Chengyin Min; Vickery Trinkaus-Randall; Dany Chalbos; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2009-05-11       Impact factor: 4.272

View more
  24 in total

1.  Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

Authors:  César Evaristo; Stefani Spranger; Sarah E Barnes; Michelle L Miller; Luciana L Molinero; Frederick L Locke; Thomas F Gajewski; Maria-Luisa Alegre
Journal:  J Immunol       Date:  2016-02-22       Impact factor: 5.422

2.  Basal NF-κB controls IL-7 responsiveness of quiescent naïve T cells.

Authors:  Michelle L Miller; Mona Mashayekhi; Luqiu Chen; Ping Zhou; Xindong Liu; Monica Michelotti; Nicole Tramontini Gunn; Sarah Powers; Xiaoping Zhu; Cesar Evaristo; Maria-Luisa Alegre; Luciana L Molinero
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

Review 3.  Gain-of-function mutations and immunodeficiency: at a loss for proper tuning of lymphocyte signaling.

Authors:  Swadhinya Arjunaraja; Andrew L Snow
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-12

4.  IKKβ-NF-κB signaling in adult chondrocytes promotes the onset of age-related osteoarthritis in mice.

Authors:  Sarah E Catheline; Richard D Bell; Luke S Oluoch; M Nick James; Katherine Escalera-Rivera; Robert D Maynard; Martin E Chang; Christopher Dean; Elizabeth Botto; John P Ketz; Brendan F Boyce; Michael J Zuscik; Jennifer H Jonason
Journal:  Sci Signal       Date:  2021-09-21       Impact factor: 8.192

Review 5.  Role of diacylglycerol kinases in T cell development and function.

Authors:  Sruti Krishna; Xiaoping Zhong
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

6.  Leukemia cell-derived microvesicles induce T cell exhaustion via miRNA delivery.

Authors:  Jieke Cui; Qing Li; Mei Luo; Zhaodong Zhong; Shu Zhou; Lin Jiang; Na Shen; Zhe Geng; Hui Cheng; Li Meng; Shujuan Yi; Hui Sun; Feifei Wu; Zunmin Zhu; Ping Zou; Yong You; An-Yuan Guo; Xiaojian Zhu
Journal:  Oncoimmunology       Date:  2018-03-26       Impact factor: 8.110

Review 7.  A new look at T cell receptor signaling to nuclear factor-κB.

Authors:  Suman Paul; Brian C Schaefer
Journal:  Trends Immunol       Date:  2013-03-07       Impact factor: 16.687

8.  Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors.

Authors:  Jonathan Fisher; Roshan Sharma; Dilu Wisidagamage Don; Marta Barisa; Marina Olle Hurtado; Pierre Abramowski; Lucy Porter; William Day; Roberto Borea; Sarah Inglott; John Anderson; Dana Pe'er
Journal:  Sci Signal       Date:  2019-09-10       Impact factor: 8.192

9.  T cell Receptor Signal Transduction in T lymphocytes.

Authors:  Balachandra K Gorentla; Xiao-Ping Zhong
Journal:  J Clin Cell Immunol       Date:  2012-10-27

10.  Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.

Authors:  Andrew L Snow; Wenming Xiao; Jeffrey R Stinson; Wei Lu; Benjamin Chaigne-Delalande; Lixin Zheng; Stefania Pittaluga; Helen F Matthews; Roland Schmitz; Sameer Jhavar; Stefan Kuchen; Lela Kardava; Wei Wang; Ian T Lamborn; Huie Jing; Mark Raffeld; Susan Moir; Thomas A Fleisher; Louis M Staudt; Helen C Su; Michael J Lenardo
Journal:  J Exp Med       Date:  2012-11-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.